Historical source-based research. Compilation date and financial period are different dates.
Research summary
A two-period review of LIN revenue, profitability and cash conversion; reported revenue growth was 2.97%.
Period comparison
FY2025 ended 2025-12-31; the prior observation ended 2024-12-31. Revenue moved from USD 33.005 billion to USD 33.986 billion. These are annual periods, not quarterly earnings or trailing-twelve-month estimates.
Earnings bridge
Net income moved from USD 6.565 billion to USD 6.898 billion. Operating income moved from USD 8.635 billion to USD 8.923 billion. Net margin moved from 19.89% to 20.30%. A margin change identifies an outcome; its causes require management discussion and footnotes.
Cash-flow cross-check
Operating cash flow was USD 9.423 billion in the earlier period and USD 10.350 billion in the later period. Selected free cash flow was USD 4.926 billion and USD 5.089 billion, respectively. Working-capital timing can cause earnings and cash to diverge.
Interpretation and limits
A rise in reported revenue does not by itself identify organic growth. A difference in EPS can reflect share-count changes as well as operating performance. No causal claim is made from these aggregate figures.
Valuation context
Company profiles show eligible dated valuation ratios using the September 17, 2026 price snapshot and selected annual accounting denominators. Capitalization-based measures use estimates and are identified as such. These are not live, TTM or forward values. A historical-multiple series and EV/EBITDA are not available. Sector medians describe a selected sample; they do not establish fair value or expected returns.
What to monitor
Volumes, realized prices, reinvestment and through-cycle cash generation.
Risks and uncertainties
Commodity pricing, production disruption, reserve quality, energy costs and capital execution.
Sources & dates
- SEC annual filing · 2025-12-31 ↗Source date 2026-02-25
- SEC annual filing · 2024-12-31 ↗Source date 2026-02-25
- SEC annual filing · 2023-12-31 ↗Source date 2026-02-25
- SEC annual filing · 2022-12-31 ↗Source date 2025-02-26
- SEC issuer record ↗Source date 2026-09-18